Comparing Wide- and Narrow-angle Digital Breast Tomosynthesis for Breast Masses

This observational study is comparing two types of Digital Breast Tomosynthesis (DBT) (a special type of mammogram that takes multiple images to create a 3D picture of the breast): wide-angle DBT and narrow-angle DBT. The main goal is to see if wide-angle DBT images are better at showing breast masses and architectural distortions (changes in the normal breast tissue pattern) than narrow-angle DBT. Researchers also want to gather feedback from radiologists and technologists, and understand participant comfort. You may be able to join if you are a woman having a standard screening mammogram and can understand and sign consent. Pregnant women and men cannot participate. The current recruitment status is unclear, and the study plans to enroll 100 participants.

Study design
This is an observational study planning to enroll 100 women. It compares two types of Digital Breast Tomosynthesis (DBT).
What's involved
You would undergo tomosynthesis imaging as part of your standard screening mammography.
Compensation
Not stated in the trial record.
Follow-up
Safety and adverse events (AEs) will be measured through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06373354

Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems

Recruiting
Not specifiedAll AgesObservational
M.D. Anderson Cancer Center
~100 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:Digital Breast Tomosynthesis (DBT)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety and adverse events (AEs)
Measured over Through study completion; an average of 1 year
Architectural Distortions
Breast Tomosynthesis
1 sites across 1 states
Texas1
  • Beatriz Adrada, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women undergoing standard screening mammography.
Ability to understand and sign consent.

Exclusion

Pregnant women.
Women unable to consent.
Male patients.
  • Safety and adverse events (AEs)Through study completion; an average of 1 year

    ncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events